Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Hoechst discovers inhibitors of various inflammatory mediators

March 25, 1998

CytoMed and UCB join forces to develop antiinflammatory therapeutics

March 25, 1998

PathoGenesis seeks Canadian approval for TOBI in CF

March 25, 1998

New antiasthmatic agents claimed by Byk Gulden

March 25, 1998

Epi-2010, a novel antisense oligonucleotide for asthma

March 24, 1998

Jak-2 inhibitor indicated for control of allergic inflammation

March 24, 1998

Clinical efficacy demonstrated for rhuMAb-E25 in asthma

March 24, 1998

PPL's AAT granted orphan drug status by FDA

March 24, 1998

Preliminary clinical efficacy demonstrated for PDE III inhibitor in asthma

March 24, 1998

Phase III trial of Procysteine i.v. suspended

March 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...